PCN97 COST EFFECTIVENESS OF ERLOTINIB TREATMENT GIVEN BY A CLINICALLY BASED APPROACH AND AN EGFR/KRAS TESTING-GUIDED APPROACH ADVANCED IN NON SMALL-CELL LUNG CANCER- A PROSPECTIVE MULTICENTRIC FRENCH STUDY (ERMETIC)
Abstract
Authors
I Borget J Cadranel JP Pignon G Danton B Coudert E Dansin S Friard C Daniel E Quoix J Madeleine A Madroszyk F Morin C Chouaid